Charles Greg Guyer - 29 Apr 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
29 Apr 2022
Net transactions value
-$317,171
Form type
4
Filing time
06 May 2022, 20:19:02 UTC
Previous filing
17 Mar 2022
Next filing
10 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $15,165 +243 +0.47% $62.41 52,299 29 Apr 2022 Direct F1
transaction BMRN Common Stock Tax liability $332,336 -3,926 -7.5% $84.65 48,373 04 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.